Healthcare-Associated Infections
Learning Objectives
Introduction
At the end of this module, the learner will be able to:
- Describe the adverse health and economic consequences of healthcare-associated infections.
- Summarize how surveillance of healthcare-associated infections is performed and how these data can be used for local quality-improvement activities.
- Discuss how public reporting of healthcare-associated infection data is being implemented and used by healthcare consumers and payers.
Device Associated Infections
At the end of this module, the learner will be able to:
- Describe the pathogenesis of CLABSI, CAUTI and VAP.
- List the most effective strategies to prevent CLABSI, CAUTI and VAP.
- Explain the difference between surveillance definitions for device-associated infections and the clinical syndromes, and explain why the difference exists.
Multidrug-Resistant Organisms: MRSA, CRE, VRE, ESBL
At the end of this module, the learner will be able to:
- State the definition of multidrug resistance, common mechanisms of resistance, and identify organisms which are typically classified as Multidrug-Resistant Organisms (MDROs).
- Compare and contrast the differences in resistance testing conducted using phenotypic and genotypic methods.
- Identify the impact of common Multidrug-Resistant Organisms (MDROs) in the care of hospitalized patients.
- Describe the differences between vertical and horizontal transmission, and discuss the interventions that prevent the emergence and spread of MDROs.
C. difficile
At the end of this module, the learner will be able to:
- Summarize risk factors for C. difficile infection
- Discuss testing strategies for detecting C. difficile infection including limitations and factors which may impact testing outcomes
- Describe transmission-based precautions and environmental cleaning practices to prevent the spread of C. difficile
Surgical Site Infections
At the end of this module, the learner will be able to:
- Define the frequency and impact of SSI.
- Describe the epidemiology and risk factors of SSI.
- Identify prevention strategies especially as they impact physicians in training.
Introduction
Original Author: Christopher Crnich, MD |
Device Associated Infections
Original Author: E. Yoko Furuya, MD, MS |
Multidrug-Resistant Organisms: MRSA, CRE, VRE, ESBL
Original/Revising Author: Sorabh Dhar, MD | Original/Revising Author: Anupama Neelakanta, MD, MPH | Original/Revising Author: Sarit Sharma, MD |
Original Contributing Author: Keith Kaye, MD | Original/Revising Contributing Author: Teena Chopra, MD, MPH | Lead Revising Author: David Banach, MD, MPH |
C. difficile
Lead Author: David Banach, MD, MPH | Contributing Author: Sarah Haessler, MD, MS
| Contributing Author: Sarit Sharma, MD |
Surgical Site Infections
Original Author: Trish Perl, MD, MSc | Revising Author: Julie Trivedi, MD |